Status:

UNKNOWN

Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome

Lead Sponsor:

National Cancer Institute, Egypt

Conditions:

Stellate Ganglion

Radiofrequency Ablation

Eligibility:

FEMALE

18-60 years

Phase:

NA

Brief Summary

The aim of this study is to evaluate the efficacy of the combination of Ultra Sound (US) guided radiofrequency stellate ganglion block (SGB) and radiofrequency Thoracic Paravertebral block (TPVB) comp...

Detailed Description

Breast cancer is the most common malignancy among females, with an incidence of about 2.1 million women each year. It is the most common cause of cancer-related deaths among women. Modified Radical Ma...

Eligibility Criteria

Inclusion

  • Female patients.
  • Type of surgery: Modified Radical Mastectomy MRM.
  • Physical status ASA II, III.
  • Duration of more than 6 months and less than 2 years.
  • Moderate and severe pain (visual analog scale \[VAS\] ≥ 40 mm).
  • Pain described as a refractory to strong opioids (oxycodone) and adjuvant therapy such as(pregabalin) for which more invasive interventions could be tried.

Exclusion

  • Patient refusal.
  • Patient with local and systemic sepsis.
  • Local anatomical distortion.
  • History of contralateral chest disease or pneumonectomy.
  • Known sensitivity or contraindication to the drug used in the study.
  • History of psychological disorders.
  • Contraindication to regional anesthesia, e.g., pre-existing peripheral neuropathies and coagulopathy.
  • Severe respiratory or cardiac disorders. Advanced liver or kidney disease.
  • Pregnancy.
  • Physical status ASA IV and Male patients.

Key Trial Info

Start Date :

October 7 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 15 2024

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT06033456

Start Date

October 7 2023

End Date

March 15 2024

Last Update

October 10 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Cancer Institute

Cairo, Egypt, 11796